Prenetics Global Ltd SEC filings PRENW
Prenetics Global Ltd has 271 filings in SEC EDGAR's recent list, going back to Sep 16, 2021. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-1/A | Filing | Sep 22, 2026 | — |
| F-1/A | Filing | Sep 8, 2026 | — |
| S-8 | Employee stock plan registration | Aug 21, 2026 | — |
| F-1/A | Filing | Aug 7, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 31, 2026 | — |
| 424B5 | Prospectus supplement | Oct 28, 2025 | — |
| 424B5 | Prospectus supplement | Oct 27, 2025 | — |
| F-3/A | Filing | Sep 8, 2025 | — |
| F-3/A | Filing | Aug 22, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 22, 2025 | — |
| S-8 | Employee stock plan registration | May 7, 2025 | — |
| S-8 | Employee stock plan registration | May 1, 2024 | — |
| 424B3 | Prospectus | Feb 16, 2024 | — |
| F-3/A | Filing | Feb 5, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 17, 2024 | — |
| 424B3 | Prospectus | Nov 2, 2023 | — |
| POS AM | Post-effective amendment no. 5 to form f-1 on form f-3 | Oct 6, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 29, 2023 | — |
| 424B3 | Prospectus | Jul 21, 2023 | — |
| POS AM | Post-effective amendment no. 4 to form f-1 | Jul 6, 2023 | — |
| POS AM | Post-effective amendment no. 3 to form f-1 | May 31, 2023 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | May 1, 2023 | — |
| S-8 | Employee stock plan registration | May 1, 2023 | — |
| 424B3 | Prospectus | Jan 17, 2023 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Dec 14, 2022 | — |
| S-8 | Employee stock plan registration | Oct 20, 2022 | — |
| 424B3 | Prospectus | Jul 1, 2022 | — |
| F-1/A | Filing | Jun 28, 2022 | — |
| F-1/A | Filing | Jun 21, 2022 | — |
| F-1/A | Filing | Jun 10, 2022 | — |
| F-1 | Registration statement (foreign issuer) | May 27, 2022 | — |
| 424B3 | Prospectus | May 4, 2022 | — |
| 424B3 | Prospectus | Apr 11, 2022 | — |
| F-4/A | Filing | Apr 6, 2022 | — |
| F-4/A | Filing | Mar 30, 2022 | — |
| F-4/A | Filing | Mar 4, 2022 | — |
| F-4/A | Filing | Feb 18, 2022 | — |
| F-4/A | Filing | Feb 10, 2022 | — |
| F-4/A | Filing | Jan 19, 2022 | — |
| F-4/A | Form f-4/a | Dec 30, 2021 | — |
| F-4/A | Filing | Dec 16, 2021 | — |
| F-4/A | Filing | Nov 30, 2021 | — |
| F-4 | Form f-4 | Nov 9, 2021 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRE (Nasdaq), PRENW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Quarry Bay, Hong Kong
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1876431
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.